Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ox_zoo
    Junior Member
    • Nov 2016
    • 5

    #1

    slight over clustering?

    Hello,

    I have, this morning, set up a Next-Seq run for some ChIP-seq libraries. It is now on its 39th cycle. However, the cluster PF value is 75.94 yet the %≥Q30 is at 90.82. I have around 150,000,000 reads per lane...


    I was wondering is this a case of over-clustering? If so, are the reads not as usable?
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    With those read numbers it has over clustered. Q30 score for that cycle is lower than scores for a standard run. You will expect that Q score will fall lower as the cycles number increases.

    Reads would be usable and depending on downstream application more or less trimming would be required.

    Comment

    • jdk787
      josh kinman
      • Apr 2014
      • 72

      #3
      Also, if the NextSeq is like other Illumina machines your index read quality will be affected more negatively than the R1 and R2 reads. This can cause a loss of data from unidentifiable indices during demultiplexing.
      Josh Kinman

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Today, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      68 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...